Publications (1)18.37 Total impact
-
Article: Successful treatment of leptomeningeal disease in colorectal cancer with a regimen of bevacizumab, temozolomide, and irinotecan.
Journal of Clinical Oncology 06/2007; 25(13):e14-6. · 18.37 Impact Factor
